We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,756 hedge funds and large institutions have $252B invested in Johnson & Johnson in 2019 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 1,129 increasing their positions, 1,289 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 66

4.93% more ownership

Funds ownership: 68.05%72.98% (+4.9%)

0% less funds holding

Funds holding: 2,7662,756 (-10)

0% less capital invested

Capital invested by funds: $253B → $252B (-$1.14B)

7% less funds holding in top 10

Funds holding in top 10: 690639 (-51)

11% less call options, than puts

Call options by funds: $1.69B | Put options by funds: $1.9B

12% less repeat investments, than reductions

Existing positions increased: 1,129 | Existing positions reduced: 1,289

Holders
2,756
Holders Change
-10
Holders Change %
-0.36%
% of All Funds
59.85%
Holding in Top 10
639
Holding in Top 10 Change
-51
Holding in Top 10 Change %
-7.39%
% of All Funds
13.88%
New
91
Increased
1,129
Reduced
1,289
Closed
66
Calls
$1.69B
Puts
$1.9B
Net Calls
-$208M
Net Calls Change
+$260M
Name Holding Trade Value Shares
Change
Change in
Stake
BRWM
2751
B. Riley Wealth Management
Tennessee
$3.8K +$58.7K +424 +2%
CPIA
2752
Cornell Pochily Investment Advisors
New York
$3.74K +$997K +7,204 +37%
LHC
2753
Little House Capital
Massachusetts
$2.99K +$189K +1,365 +6%
CT
2754
Chicago Trust
Illinois
$2.91K -$278K -2,005 -9%
ACA
2755
Ackerman Capital Advisors
Texas
$1.03K -$55K -397 -5%
WIM
2756
Westside Investment Management
California
$663 +$660K +4,767 New
Sanders Capital
2757
Sanders Capital
Florida
-$356M -2,546,739 Closed
HI
2758
HBK Investments
Texas
-$39.5M -282,616 Closed
PC
2759
Polar Capital
United Kingdom
-$37.2M -266,000 Closed
EIP
2760
Easterly Investment Partners
Massachusetts
-$32.8M -234,496 Closed
CIM
2761
Confluence Investment Management
Missouri
-$26.9M -192,101 Closed
DA
2762
Duality Advisers
Florida
-$17.3M -123,880 Closed
Marshall Wace
2763
Marshall Wace
United Kingdom
-$14.7M -105,502 Closed
Simplex Trading
2764
Simplex Trading
Illinois
-$11.2M -81,179 Closed
PWPCM
2765
Perella Weinberg Partners Capital Management
New York
-$7.73M -55,312 Closed
CCP
2766
Clough Capital Partners
Massachusetts
-$6.16M -44,089 Closed
MFAM
2767
Motley Fool Asset Management
Virginia
-$6.07M -43,387 Closed
TAL
2768
TIG Advisors LLC
New York
-$5.19M -40,223 Closed
OFCM
2769
One Fin Capital Management
California
-$5.31M -38,000 Closed
ACM
2770
Academy Capital Management
Texas
-$4.56M -32,644 Closed
EP
2771
Edgestream Partners
New Jersey
-$4.46M -31,936 Closed
PCM
2772
Palouse Capital Management
Washington
-$4.44M -31,794 Closed
Hudson Bay Capital Management
2773
Hudson Bay Capital Management
Connecticut
-$3.96M -28,300 Closed
SIP
2774
Stoneridge Investment Partners
Pennsylvania
-$3.85M -27,516 Closed
COI
2775
Connable Office Inc
Michigan
-$3.25M -23,245 Closed

JNJ Hedge Fund Activity: Q2 2019 in Review

2,756 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2019, worth a combined $252B — down 0.45% from $253B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new JNJ positions and 66 closed out — a net gain of 25 holders — while 1,129 added to existing stakes and 1,289 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $17.3B. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $719M.

  • 2,756 institutional investors held Johnson & Johnson (JNJ) as of Q2 2019, down from 2,766 in Q1 2019.
  • Funds reported $252B of Johnson & Johnson stock for Q2 2019, down 0.45% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q2 2019 and 66 closed out, a net change of +25 holders.
  • The largest Johnson & Johnson buyer in Q2 2019 was Phocas Financial Corp, an estimated $17.3B added.
  • The largest Johnson & Johnson seller in Q2 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $719M sold.

Based on aggregated 13F filings for Q2 2019.